Envoy Medical Research and Development Expenses 2021-2024 | COCH
Envoy Medical research and development expenses from 2021 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.
| Envoy Medical Annual Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2024 | $10 |
| 2023 | $9 |
| 2022 | $5 |
| 2021 | $0 |
| 2020 | $0 |
| Envoy Medical Quarterly Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2024-12-31 | $2 |
| 2024-09-30 | $3 |
| 2024-06-30 | $3 |
| 2024-03-31 | $2 |
| 2023-12-31 | $3 |
| 2023-09-30 | $2 |
| 2023-06-30 | $2 |
| 2023-03-31 | $2 |
| 2022-12-31 | $4 |
| 2022-09-30 | $1 |
| 2022-06-30 | |
| 2022-03-31 | |
| 2021-12-31 | |
| 2021-09-30 | |
| 2021-06-30 | |
| 2021-03-31 | |
| 2020-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED INSTRUMENTS | $0.029B | $0.000B |
| Envoy Medical Inc. is a medical technology company focused on fully implanted hearing devices. The company's primary device is the fully implanted Acclaim(R) cochlear implant. Envoy Medical Inc., formerly known as Anzu Special Acquisition Corp I, is headquartered in White Bear Lake, Minnesota. | |||